Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
January 22 2024 - 5:00PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of January 2024
Commission File Number: 001-41660
YanGuFang International Group Co., Ltd.
3/F, Building 3
33 Suhong Road, Minhang District
Shanghai, China, 201100
(Address of principal executive offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒
Form 40-F ☐
Explanatory Note
Mr. Jiangping Xiao, an independent director of YanGuFang
International Group Co., Ltd. (the “Company”), resigned from the board of directors of the Company (“Board”) and
all committees thereof, due to personal reasons, effective January 16, 2024. On January 18, 2024, the Board accepted Mr. Xiao’s
resignation. Mr. Xiao’s resignation was not due to any disagreement on any matter relating to the Company’s operations, policies
or practices.
On January 19, 2024, the Company received a
deficiency notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a
result of the resignation of Mr. Xiao from the Board and the audit committee of the Board (the “Audit Committee”), the Company
is no longer in compliance with Nasdaq’s independent director and audit committee requirement as set forth in Listing Rule 5605.
The Notice states that, consistent with Listing Rule 5605(b)(1)(A) and 5605(c)(4), Nasdaq will provide the Company a cure period until
the earlier of the Company’s next annual shareholders’ meeting or January 16, 2025 to regain compliance; provided that if
the next annual shareholders’ meeting is held before July 15, 2024, then the Company must evidence compliance no later than July
15, 2024.
If compliance is not achieved by the expiration
of the cure period, the Company’s securities will be subject to delisting. At that time, the Company may appeal the delisting determination
to a Hearings Panel. We plan to search for candidates and fill in the vacancy on the Board and the Audit Committee within the cure period
provided by Nasdaq.
The Notice has no immediate impact on the listing of the Company’s
ordinary shares on Nasdaq.
As previously reported, on November 15, 2023, the Company received written
notice from Nasdaq notifying the Company of its noncompliance with the Nasdaq Listing Rule 5250 (c)(1) for continued listing due to its
failure to file its Annual Report on the Form 20-F for the fiscal year ended June 30, 2023 in a timely manner. On January 19, 2024, the
Company submitted its plan of compliance to Nasdaq.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
YanGuFang International Group Co., Ltd. |
|
|
|
Date: January 22, 2024 |
By: |
/s/ Ya Zhang |
|
Name: |
Ya Zhang |
|
Title: |
Interim Chief Executive Officer |
2
YanGuFang (NASDAQ:YGF)
Historical Stock Chart
From Jul 2024 to Aug 2024
YanGuFang (NASDAQ:YGF)
Historical Stock Chart
From Aug 2023 to Aug 2024